Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?
In Brief; “Sense of Urgency” In Research Is Theme of New AACR President Daniel Von Hoff
Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time
CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years
Komen, ACS Support Payment Off-Protocol; Dilemma for Advocates
NCI Programs: Pediatric Brain Tumor Grants Awarded
Trending Stories
- She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine - First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI - Imaging’s ride to the bottom in clinical trials—and why it matters now
- In The Headlines: What happens when you apply a tumor board model to financial toxicity?